Abstract
BackgroundEarly, intensive disease-modifying anti-rheumatic drug (DMARD) therapy is an effective strategy to limit disease progression in rheumatoid arthritis (RA). It was recently reported that DMARD therapy is initiated in advance...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have